异动解读 | 齐默巴奥米特控股下调销售预期，股价盘前大跌8.90%

异动解读

Nov 05, 2025

医疗设备制造商齐默巴奥米特控股（Zimmer Biomet Holdings，股票代码：ZBH）今日盘前股价大跌8.90%，引发市场关注。这一显著跌幅主要源于公司下调了2025年的有机销售增长预期。

根据公司最新公告，齐默巴奥米特将2025年有机销售增长预期的上限从4.5%下调至4.0%，而下限则维持在3.5%。这一调整反映了公司在国际市场面临的挑战，特别是拉丁美洲和欧洲新兴市场的疲软表现抵消了其在美国市场的强劲业绩。公司表示，这些问题是在本季度末出现的，目前正在积极采取措施解决。

尽管面临挑战，齐默巴奥米特的第三季度业绩仍然喜忧参半。公司报告季度收入为20亿美元，基本符合分析师预期。调整后每股收益为1.90美元，略高于分析师平均预期的1.87美元。公司的髋关节和膝关节产品需求强劲，反映了老年人口对关节重建手术需求的持续增长。然而，运动医学、四肢和创伤部门的销售额虽然增长了19%，达到5.415亿美元，但仍低于市场预期。摩根大通分析师罗比·马库斯评论道，尽管季度利润超出预期，但投资者的焦点可能集中在有机销售增长未达预期这一事实上。这种复杂的业绩表现，加上对未来增长的担忧，共同导致了投资者信心的下降，引发了股价的大幅调整。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1183364403"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183364403\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183364403?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-11-05 20:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183364403","market":"us","top_or_hot":-1,"title":"异动解读 | 齐默巴奥米特控股下调销售预期，股价盘前大跌8.90%","media":"异动解读","content":"<p>医疗设备制造商齐默巴奥米特控股（Zimmer Biomet Holdings，股票代码：ZBH）今日盘前股价大跌8.90%，引发市场关注。这一显著跌幅主要源于公司下调了2025年的有机销售增长预期。</p>\n\n<p>根据公司最新公告，齐默巴奥米特将2025年有机销售增长预期的上限从4.5%下调至4.0%，而下限则维持在3.5%。这一调整反映了公司在国际市场面临的挑战，特别是拉丁美洲和欧洲新兴市场的疲软表现抵消了其在美国市场的强劲业绩。公司表示，这些问题是在本季度末出现的，目前正在积极采取措施解决。</p>\n\n<p>尽管面临挑战，齐默巴奥米特的第三季度业绩仍然喜忧参半。公司报告季度收入为20亿美元，基本符合分析师预期。调整后每股收益为1.90美元，略高于分析师平均预期的1.87美元。公司的髋关节和膝关节产品需求强劲，反映了老年人口对关节重建手术需求的持续增长。然而，运动医学、四肢和创伤部门的销售额虽然增长了19%，达到5.415亿美元，但仍低于市场预期。摩根大通分析师罗比·马库斯评论道，尽管季度利润超出预期，但投资者的焦点可能集中在有机销售增长未达预期这一事实上。这种复杂的业绩表现，加上对未来增长的担忧，共同导致了投资者信心的下降，引发了股价的大幅调整。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 齐默巴奥米特控股下调销售预期，股价盘前大跌8.90%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 齐默巴奥米特控股下调销售预期，股价盘前大跌8.90%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-11-05 20:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>医疗设备制造商齐默巴奥米特控股（Zimmer Biomet Holdings，股票代码：ZBH）今日盘前股价大跌8.90%，引发市场关注。这一显著跌幅主要源于公司下调了2025年的有机销售增长预期。</p>\n\n<p>根据公司最新公告，齐默巴奥米特将2025年有机销售增长预期的上限从4.5%下调至4.0%，而下限则维持在3.5%。这一调整反映了公司在国际市场面临的挑战，特别是拉丁美洲和欧洲新兴市场的疲软表现抵消了其在美国市场的强劲业绩。公司表示，这些问题是在本季度末出现的，目前正在积极采取措施解决。</p>\n\n<p>尽管面临挑战，齐默巴奥米特的第三季度业绩仍然喜忧参半。公司报告季度收入为20亿美元，基本符合分析师预期。调整后每股收益为1.90美元，略高于分析师平均预期的1.87美元。公司的髋关节和膝关节产品需求强劲，反映了老年人口对关节重建手术需求的持续增长。然而，运动医学、四肢和创伤部门的销售额虽然增长了19%，达到5.415亿美元，但仍低于市场预期。摩根大通分析师罗比·马库斯评论道，尽管季度利润超出预期，但投资者的焦点可能集中在有机销售增长未达预期这一事实上。这种复杂的业绩表现，加上对未来增长的担忧，共同导致了投资者信心的下降，引发了股价的大幅调整。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZBH","symbol_name":"齐默巴奥米特控股","start_time":0,"source_url":"","article_id":"1183364403","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183364403","pubTimestamp":1762347389,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"医疗设备制造商齐默巴奥米特控股今日盘前股价大跌8.90%，引发市场关注。根据公司最新公告，齐默巴奥米特将2025年有机销售增长预期的上限从4.5%下调至4.0%，而下限则维持在3.5%。尽管面临挑战，齐默巴奥米特的第三季度业绩仍然喜忧参半。公司的髋关节和膝关节产品需求强劲，反映了老年人口对关节重建手术需求的持续增长。这种复杂的业绩表现，加上对未来增长的担忧，共同导致了投资者信心的下降，引发了股价的大幅调整。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ZBH":"齐默巴奥米特控股"},"translate_title":"Interpretation of changes | Zimmerba Omit Holdings lowered its sales forecast, and its stock price fell 8.90% before the market opened.","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZBH":1},"content_text":"医疗设备制造商齐默巴奥米特控股（Zimmer Biomet Holdings，股票代码：ZBH）今日盘前股价大跌8.90%，引发市场关注。这一显著跌幅主要源于公司下调了2025年的有机销售增长预期。\n根据公司最新公告，齐默巴奥米特将2025年有机销售增长预期的上限从4.5%下调至4.0%，而下限则维持在3.5%。这一调整反映了公司在国际市场面临的挑战，特别是拉丁美洲和欧洲新兴市场的疲软表现抵消了其在美国市场的强劲业绩。公司表示，这些问题是在本季度末出现的，目前正在积极采取措施解决。\n尽管面临挑战，齐默巴奥米特的第三季度业绩仍然喜忧参半。公司报告季度收入为20亿美元，基本符合分析师预期。调整后每股收益为1.90美元，略高于分析师平均预期的1.87美元。公司的髋关节和膝关节产品需求强劲，反映了老年人口对关节重建手术需求的持续增长。然而，运动医学、四肢和创伤部门的销售额虽然增长了19%，达到5.415亿美元，但仍低于市场预期。摩根大通分析师罗比·马库斯评论道，尽管季度利润超出预期，但投资者的焦点可能集中在有机销售增长未达预期这一事实上。这种复杂的业绩表现，加上对未来增长的担忧，共同导致了投资者信心的下降，引发了股价的大幅调整。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}